The landscape of immunotherapy has undergone a seismic shift over the last decade. While monoclonal antibodies (mAbs) laid the foundation for targeted treatment, the emergence of bispecific antibodies (BsAbs) has opened doors to therapeutic possibilities that were once deemed ...Learn More

Keywords: Ex Vivo Skin Models, Naturally Occurring Skin Disease Model, Phenotypic Skin Disease Model, Fibroblast Activation Assay, Psoriasis Model, 3D BiologyIntroduction: The "Ethics vs. Authenticity" Challenge in DermatologyIn dermatological drug screening and cosmetic efficacy ...Learn More

The human microbiome is no longer a "hidden organ" but a central pillar of modern precision medicine. As we move through 2026, the shift from merely mapping microbial diversity to engineering functional cures has birthed a rapidly expanding field: Live Biotherapeutic Products ...Learn More

The landscape of modern medicine is shifting. As we move away from "one-size-fits-all" treatments toward precision medicine, the pressure on preclinical drug discovery has never been greater. For researchers, the challenge lies in bridging the gap between laboratory benchwork and ...Learn More

As we progress through the first quarter of 2026, the landscape of targeted cancer therapy is undergoing a significant transformation. Among the most promising modalities, Antibody-Drug Conjugates (ADCs) continue to dominate the discussion, particularly with the emergence of ...Learn More